岭南急诊医学杂志2024,Vol.29Issue(5) :462-465,469.DOI:10.3969/j.issn.1671-301X.2024.05.004

S100β对重症肺炎患者预后评估的价值

The Value of S100β in Prognostic Assessment of Patients with Severe Pneumonia

王楚悦 程净歌 黎博 刘可可 胡春林 廖晓星
岭南急诊医学杂志2024,Vol.29Issue(5) :462-465,469.DOI:10.3969/j.issn.1671-301X.2024.05.004

S100β对重症肺炎患者预后评估的价值

The Value of S100β in Prognostic Assessment of Patients with Severe Pneumonia

王楚悦 1程净歌 1黎博 1刘可可 1胡春林 1廖晓星1
扫码查看

作者信息

  • 1. 中山大学附属第七医院(518107)
  • 折叠

摘要

目的:探讨S100β对重症肺炎患者预后的评估价值.方法:以出院作为研究的观察终点,对2021年5月至2023年10月期间中山大学附属第一医院急诊科收治的107例重症肺炎患者的资料进行回顾性分析,根据S100β的血清学浓度分为阴性组和阳性组,根据患者出院存活状态分为存活组及死亡组,用GCS评分评估患者入院时神志,用CURB-65评分、SOFA评分、APACHE II评分、PSI指数评估重症肺炎患者病情严重程度,采用出院时存活情况、机械通气时间(天)、去甲肾上腺素剂量(mg)、CRRT时间(天)评估重症肺炎患者预后.结果:107例重症肺炎患者中S100β阳性组的患者48人(44.9%),阴性患者59人(55.1%).S100β阳性患者GCS评分低于S100β阴性患者,SOFA评分高于S100β阴性患者.S100β阳性组的患者住院期间机械通气时间、去甲肾上腺素使用剂量、CRRT治疗时长均高于S100β阴性患者.S100β阳性组的患者院内死亡率(62.5%)显著高于S100β阴性患者的(23.7%).S100β联合SOFA评分及APACHE II评分预测重症肺炎预后时,能辅助原有评分,提高诊断的特异性.结论:重症肺炎患者脑损伤发生率较高,可达44.9%,S100β能反映重症肺炎患者的病情严重程度,是预测重症肺炎患者预后不良的独立危险因素.

Abstract

Objective:To explore the value of S100β in assessing the prognosis of patients with severe pneumonia.Methods:With hospital discharge as the study's primary endpoint,we conducted a retrospective analysis of data on 107 patients with severe pneumonia admitted to the emergency department of the First Affiliated Hospital of Sun Yat-sen Uni-versity from May 2021 to October 2023.Patients were categorized into S100β-negative and S100β-positive groups based on their serum S100β levels,and into survival and non-survival groups based on their discharge outcomes.The Glasgow Coma Scale(GCS)score was used to evaluate the level of consciousness on admission,and the CURB-65 score,Se-quential Organ Failure Assessment(SOFA)score,Acute Physiology and Chronic Health Evaluation(APACHE)II score,and the Pneumonia Severity Index(PSI)were used to assess the severity of the patients'conditions.The progno-sis of patients with severe pneumonia was evaluated based on survival status at discharge,duration of mechanical ventila-tion(days),dose of norepinephrine(mg),and duration of continuous renal replacement therapy(CRRT)(days).Re-sults:Among the 107 patients with severe pneumonia,there were 48(44.9%)in the S100β-positive group and 59(55.1%)in the S100β-negative group.Patients in the S100β-positive group had lower Glasgow Coma Scale(GCS)scores and higher Sequential Organ Failure Assessment(SOFA)scores compared to those in the S100β-negative group.The duration of mechanical ventilation,the dose of norepinephrine used,and the length of continuous renal replacement therapy(CRRT)treatment during hospitalization were all higher in the S100β-positive group than in the S100β-negative group.The in-hospital mortality rate in the S100β-positive group(62.5%)was significantly higher than that in the S100β-negative group(23.7%).The combination of S100β with SOFA score and APACHE II score in predicting the prognosis of severe pneumonia can complement the existing scores and improve the specificity of diagnosis.Conclusion:The inci-dence of brain injury in patients with severe pneumonia is relatively high,reaching 44.9%.S100β can reflect the sever-ity of the disease in patients with severe pneumonia and serves as an independent risk factor for predicting an unfavorable prognosis in patients with severe pneumonia.

关键词

重症肺炎/S100β/预后

Key words

Severe pneumonia/S-100 beta protein/Prognosis

引用本文复制引用

出版年

2024
岭南急诊医学杂志
广东省医学会

岭南急诊医学杂志

影响因子:0.437
ISSN:1671-301X
段落导航相关论文